KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Assets: 2009-2025

Historic Assets for Neogenomics (NEO) over the last 16 years, with Sep 2025 value amounting to $1.4 billion.

  • Neogenomics' Assets fell 16.23% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year decrease of 16.23%. This contributed to the annual value of $1.6 billion for FY2024, which is 2.57% down from last year.
  • According to the latest figures from Q3 2025, Neogenomics' Assets is $1.4 billion, which was down 1.38% from $1.4 billion recorded in Q2 2025.
  • Neogenomics' Assets' 5-year high stood at $1.9 billion during Q3 2021, with a 5-year trough of $1.4 billion in Q3 2025.
  • Its 3-year average for Assets is $1.6 billion, with a median of $1.6 billion in 2024.
  • In the last 5 years, Neogenomics' Assets spiked by 6,216.82% in 2021 and then dropped by 16.23% in 2025.
  • Neogenomics' Assets (Quarterly) stood at $1.9 billion in 2021, then fell by 6.94% to $1.7 billion in 2022, then dropped by 3.38% to $1.7 billion in 2023, then fell by 2.57% to $1.6 billion in 2024, then dropped by 16.23% to $1.4 billion in 2025.
  • Its last three reported values are $1.4 billion in Q3 2025, $1.4 billion for Q2 2025, and $1.6 billion during Q1 2025.